1-6 of 6
Authors: Colin R. Dunstan
Journal Article
The Inhibition of RANKL Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared with Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy Get access
Endocrinology, Volume 146, Issue 8, 1 August 2005, Pages 3235–3243, https://doi.org/10.1210/en.2004-1583
Published: 01 August 2005
Journal Article
Fibroblast Growth Factor 23: A Phosphatonin Regulating Phosphate Homeostasis? Get access
Endocrinology, Volume 145, Issue 7, 1 July 2004, Pages 3084–3086, https://doi.org/10.1210/en.2004-0354
Published: 01 July 2004
Journal Article
OPG and PTH-(1–34) Have Additive Effects on Bone Density and Mechanical Strength in Osteopenic Ovariectomized Rats Get access
Endocrinology, Volume 142, Issue 10, 1 October 2001, Pages 4295–4304, https://doi.org/10.1210/endo.142.10.8437
Published: 01 October 2001
Journal Article
The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated*This work was supported by Grant AG-04875 from the National Institute on Aging. Get access
Endocrinology, Volume 141, Issue 12, December 2000, Pages 4768–4776, https://doi.org/10.1210/endo.141.12.7840
Published: 01 December 2000
Journal Article
Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis Get access
Endocrinology, Volume 140, Issue 10, 1 October 1999, Pages 4382–4389, https://doi.org/10.1210/endo.140.10.7034
Published: 01 October 1999
Journal Article
Estrogen Stimulates Gene Expression and Protein Production of Osteoprotegerin in Human Osteoblastic Cells* Get access
Endocrinology, Volume 140, Issue 9, 1 September 1999, Pages 4367–4370, https://doi.org/10.1210/endo.140.9.7131
Published: 01 September 1999
